Thrombus formation on a left atrial appendage closure device

Circulation

Volumn 124, Issue 14, 2011, Pages 1595-1596

  Cardona, Lorette ^a   Ana, Galrinho ^a   Luísa, Branco ^a   Leal, Ana ^a   António, Fiarresga ^a   Lídia, Sousa ^a   Cruz, Ferreira Rui ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; HEPARIN;

AGED; ANTICOAGULANT THERAPY; CASE REPORT; DRUG WITHDRAWAL; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEMATURIA; HUMAN; MALE; PRIORITY JOURNAL; SHORT SURVEY; THROMBOGENESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSFUSION; UNSPECIFIED SIDE EFFECT;

AGED; ANTICOAGULANTS; ASPIRIN; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; EQUIPMENT DESIGN; HEART DISEASES; HEPARIN; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; SEPTAL OCCLUDER DEVICE; THROMBOPHILIA; THROMBOSIS; TICLOPIDINE;

EID: 80053536072     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.004135     Document Type: Short Survey

References (8)

1. Cruz-Gonzalez I, Yan BP, Lam YY. Left atrial appendage exclusion: state-of-the-art. Cathet Cardiovasc Interv. 2010;75:806-813.
2. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S; Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J. 2006;27:1979-2030.
3. Bungard TJ, Ackman Ml, Ho G, Tsuyuki RT. Adequacy of anticoagulation in patient with atrial fibrillation coming to a hospital. Pharmacotherapy. 2000;20:1060-1065.
4. Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (percutaneous left atrial appendage transcatheter occlusion) study. J Am Coll Cardiol Cardiovasc Interv. 2009;2:594-600.
5. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P; PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534-542.
6. Willcoxson FE, Thomson JDR, Gibbs JL. Successful treatment of left atrial disk thrombus on an Amplatzer atrial septal defect occlude with abciximab and heparin. Heart. 2004;90:30.
7. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1000 consecutive patients. J Am Coll Cardiol. 2004;43:302-309. (Pubitemid 38201160)
8. The ACTIVE. Writing Group on behalf of the ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events: a randomized controlled trial. Lancet. 2006;367: 1903-1912.